NCT07372573Not yet recruiting
Pressurized Meter Dose Inhaler V/S Dry Powder Inhaler
Effectivenes of Pressurized Meter Dose Inhaler (PMDI) Versus Dry Powder Inhaler (DPI) in Delivering Inhaled Corticosteroid and Long Acting Beta Agonist Among Patients With Uncontrolled Asthma in a Tertiary Care Hospital.
Source: ClinicalTrials.gov · Last updated 28 Jan 2026
Brief summary (registry, in English)
This study compares two commonly used inhalation devices in asthma management. It focuses on evaluating how effectively PMDIs and DPIs deliver the same combination of inhaled corticosteroids and long-acting beta agonists in patients whose asthma remains poorly controlled despite treatment. The study is conducted in a tertiary care hospital setting, emphasizing real-world clinical practice and aiming to determine whether device choice influences asthma control outcomes.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 210 (estimated)
- First submitted
- 19 Jan 2026
- Start date
- 1 Feb 2026
- Primary completion date
- 31 Jul 2026
- Lead sponsor
- University of Health Sciences Lahore
- Diseases
- Asthma
- NCT number
- NCT07372573
What you commit to
- Study type: Interventional
- Planned participants: 210
- From 1 Feb 2026 to the primary completion date, 31 Jul 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Patients with Hypersensitivity Pneumonitis
- Patients with coexistent Interstitial Lung Disease (ILD) (confirmed on spirometry)
- Patients with coexistent cardiac asthma secondary to heart failure (diagnosed on echocardiography)
Lab values
- Patients with coexistent fungal sensitization (confirmed with peripheral eosinophil count and serum IgE)
- Patients with coexistent Allergic Bronchopulmonary Aspergillosis (ABPA) (confirmed with HRCT and serum IgE)
Other
- Patients with coexistent COPD (confirmed on spirometry)
Who the study is looking for
- Age 14 to 60 years
- Both genders
- All patients with symptoms of uncontrolled asthma
Age in the registry: 14 years to 60 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Services Hospital Lahore Coordinator of this site? Confirm its status | Lahore | Pakistan | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.